The impact of diabetes mellitus on vitamin D metabolism in predialysis patients

Bone

Volumn 45, Issue 5, 2009, Pages 949-955

  Tanaka, Hirotaka ^a   Hamano, Takayuki ^a   Fujii, Naohiko ^b   Tomida, Kodo ^a   Matsui, Isao ^a   Mikami, Satoshi ^c   Nagasawa, Yasuyuki ^a   Ito, Takahito ^a   Moriyama, Toshiki ^a   Horio, Masaru ^a   Imai, Enyu ^a   Isaka, Yoshitaka ^a   Rakugi, Hiromi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hyogo Prefectural Nishinomiya Hospital   (Japan)

^c Higashi Kori Hospital   (Japan)

Author keywords

1 84 PTH; 25 hydroxyvitamin D; Calcitriol; Diabetes mellitus; FGF 23; Proteinuria

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 25 HYDROXYVITAMIN D; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; ESTROGEN; FIBROBLAST GROWTH FACTOR 23; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; PHOSPHATE; RALOXIFENE; RECOMBINANT PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE DENSITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; OBSERVATIONAL STUDY; OSTEOCYTE; OUTPATIENT CARE; PHOSPHATE BLOOD LEVEL; PROTEIN URINE LEVEL; SEX DIFFERENCE; VITAMIN D METABOLISM;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; CALCITRIOL; CALCIUM; CARDIOVASCULAR DISEASES; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROTEINURIA; REGRESSION ANALYSIS; RENAL DIALYSIS; VITAMIN D;

EID: 70349279879     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.07.016     Document Type: Article

References (39)

1. Moe S., Drueke T., Cunningham J., Goodman W., Martin K., Olgaard K., et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 69 (2006) 1945-1953
2. Matsuoka M., Iseki K., Tamashiro M., Fujimoto N., Higa N., Touma T., et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin. Exp. Nephrol. 8 (2004) 54-58
3. Okuno S., Ishimura E., Kitatani K., Fujino Y., Kohno K., Maeno Y., et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am. J. Kidney Dis. 49 (2007) 417-425
4. Block G.A., Raggi P., Bellasi A., Kooienga L., and Spiegel D.M. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 71 (2007) 438-441
5. Kramer H., Toto R., Peshock R., Cooper R., and Victor R. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J. Am. Soc. Nephrol. 16 (2005) 507-513
6. Inaba M., Nagasue K., Okuno S., Ueda M., Kumeda Y., Imanishi Y., et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am. J. Kidney Dis. 39 (2002) 1261-1269
7. Rosato M.T., Schneider S.H., and Shapses S.A. Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif. Tissue Int. 63 (1998) 107-111
8. Achemlal L., Tellal S., Rkiouak F., Nouijai A., Bezza A., Derouiche el M., et al. Bone metabolism in male patients with type 2 diabetes. Clin. Rheumatol. 24 (2005) 493-496
9. Ivers R.Q., Cumming R.G., Mitchell P., and Peduto A.J. Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetis Care 24 (2001) 1198-1203
10. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos. Int. 18 (2007) 427-444
11. Yamamoto M., Yamaguchi T., Yamauchi M., Kaji H., and Sugimoto T. Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcif. Tissue Int. 80 (2007) 353-358
12. Danese M.D., Kim J., Doan Q.V., Dylan M., Griffiths R., and Chertow G.M. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am. J. Kidney Dis. 47 (2006) 149-156
13. Hamada Y., Kitazawa S., Kitazawa R., Fujii H., Kasuga M., and Fukagawa M. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. Bone 40 (2007) 1408-1414
14. Ashman N., Banerjee A., and Yaqoob M.M. Statins do not affect mineral metabolism in chronic kidney disease: a retrospective analysis. Nephron. Clin. Pract. 111 4 (2009) c236-c239
15. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145 (2006) 247-254
16. Mittal S.K., Dash S.C., Tiwari S.C., Agarwal S.K., Saxena S., and Fishbane S. Bone histology in patients with nephrotic syndrome and normal renal function. Kidney Int. 55 (1999) 1912-1919
17. Salamone L.M., Dallal G.E., Zantos D., Makrauer F., and Dawson-Hughes B. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am. J. Clin. Nutr. 59 (1994) 80-86
18. Mowe M., Bohmer T., and Haug E. Serum calcidiol and calcitriol concentrations in elderly people: variations with age, sex, season and disease. Clin. Nutr. 15 (1996) 201-206
19. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342 (2000) 1478-1483
20. Cozzolino M., Brancaccio D., Gallieni M., and Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 68 (2005) 429-436
21. Cozzolino M., Dusso A.S., and Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J. Am. Soc. Nephrol. 12 (2001) 2511-2516
22. Hosogane N., Shinki T., Kasuga H., Taketomi S., Toyama Y., and Suda T. Mechanisms for the reduction of 24,25-dihydroxyvitamin D3 levels and bone mass in 24-hydroxylase transgenic rats. Faseb J. 17 (2003) 737-739
23. Dobnig H., Piswanger-Solkner J.C., Roth M., Obermayer-Pietsch B., Tiran A., Strele A., et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J. Clin. Endocrinol. Metab. 91 (2006) 3355-3363
24. Yoshida O., Inaba M., Terada M., Shioi A., Nishizawa Y., Otani S., et al. Impaired response of human osteosarcoma (MG-63) cells to human parathyroid hormone induced by sustained exposure to high glucose. Miner. Electrolyte. Metab. 21 (1995) 201-204
25. Inaba M., Terada M., Koyama H., Yoshida O., Ishimura E., Kawagishi T., et al. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells. J. Bone Miner. Res. 10 (1995) 1050-1056
26. Inaba M., Nishizawa Y., Mita K., Kumeda Y., Emoto M., Kawagishi T., et al. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos. Int. 9 (1999) 525-531
27. Yoshiko Y., Wang H., Minamizaki T., Ijuin C., Yamamoto R., Suemune S., et al. Mineralized tissue cells are a principal source of FGF23. Bone 40 (2007) 1565-1573
28. Shigematsu T., Kazama J.J., Yamashita T., Fukumoto S., Hosoya T., Gejyo F., et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am. J. Kidney Dis. 44 (2004) 250-256
29. Gutierrez O., Isakova T., Rhee E., Shah A., Holmes J., Collerone G., et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J. Am. Soc. Nephrol. 16 (2005) 2205-2215
30. Marsell R., Mirza M.A., Mallmin H., Karlsson M., Mellström D., Orwoll E., et al. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men. Osteoporos. Int. (2008) Oct 31
31. Khosravi A., Cutler C.M., Kelly M.H., Chang R., Royal R.E., Sherry R.M., et al. Determination of the elimination half-life of fibroblast growth factor-23. J. Clin. Endocrinol. Metab. 92 (2007) 2374-2377
32. Villarino M.E., Sanchez L.M., Bozal C.B., and Ubios A.M. Influence of short-term diabetes on osteocytic lacunae of alveolar bone. A histomorphometric study. Acta. Odontol. Latinoam. 19 (2006) 23-28
33. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem. Biophys. Res. Commun. 314 (2004) 197-207
34. Gutiérrez O.M., Mannstadt M., Isakova T., Rauh-Hain J.A., Tamez H., Shah A., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 359 6 (2008 Aug 7) 584-592
35. Sugimoto T., Ritter C., Morrissey J., Hayes C., and Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int. 37 (1990) 1522-1527
36. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79 (2004) 820-825
37. Chonchol M., Scragg R., and 25-Hydroxyvitamin D. insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 71 (2007) 134-139
38. Wolf M., Shah A., Gutierrez O., Ankers E., Monroy M., Tamez H., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 72 (2007) 1004-1013
39. London G.M., Guerin A.P., Verbeke F.H., Pannier B., Boutouyrie P., Marchais S.J., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 18 (2007) 613-620